Authors of "Potential Impact of 68Ga-PSMA-11 PET/CT on Prostate Cancer Definitive Radiation Therapy Planning" include Jeremie Calais, Amar U. Kishan, Minsong Cao, Matthias Eiber, Francesco Ceci, Robert E. Reiter, Matthew B. Rettig, John V. Hegde, Narek Shaverdian, Chris R. King, Michael L. Steinberg, and Johannes Czernin, UCLA, Los Angeles, California; Wolfgang P. Fendler and Ken Herrmann, UCLA and University Clinic Essen, Essen, Germany; and Nicholas G. Nickols, UCLA and VA Greater Los Angeles Healthcare System.
This study was made available online on April 13, 2018, ahead of final publication in print on November 1, 2018.
Ad Statistics
Times Displayed: 50459
Times Visited: 1437 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
Please visit the SNMMI Media Center to view the PDF of the study, including images, and more information about molecular imaging and personalized medicine.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging, vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI's more than 17,000 members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice.
Back to HCB News
